 select vivo remov rheumatoid factor extracorpor treatment devic rheumatoid arthriti patient prospect phase II trial feasibl toler efficaci devic select remov rheumatoid factor plasma rheumatoid arthriti patient devic hydrogel-co plate human immunoglobulin immunoaffin column patient underw weekli plasmapheresi treatment primari therapi phase trial patient current rheumatoid arthriti medic dose adjust patient treatment primari therapi patient elig apheresi treatment week mainten therapi seriou untoward side effect cours studi treatment differ patient complaint dizzi angioedema chest tight short breath signific decreas serum iron signific chang complet blood count serum electrolyt renal hepat function test trial clinic efficaci patient morn stiff time fatigu global pain assess signific object improv joint pain tender number affect joint one-half treat patient percent improv object measur antirheumat activ